GAP-f pDTG Implementation Considerations for National Programmes
In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...
top of page
A framework to support new product introduction in national health systems
Resource Library
bottom of page